GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Invent Medic Sweden AB (XSAT:IMS) » Definitions » Cash Ratio

Invent Medic Sweden AB (XSAT:IMS) Cash Ratio : 0.23 (As of Dec. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Invent Medic Sweden AB Cash Ratio?

The Cash Ratio measures a company’s ability to meet its short-term obligations with cash and near-cash resources. It is calculated as a company's Cash, Cash Equivalents, Marketable Securities divides by its Total Current Liabilities. Invent Medic Sweden AB's Cash Ratio for the quarter that ended in Dec. 2024 was 0.23.

Invent Medic Sweden AB has a Cash Ratio of 0.23. It indicates that there are more current liabilities than Cash, Cash Equivalents, Marketable Securities, and the company does not have sufficient cash on hand to pay off its short-term debt.

The historical rank and industry rank for Invent Medic Sweden AB's Cash Ratio or its related term are showing as below:

XSAT:IMS' s Cash Ratio Range Over the Past 10 Years
Min: 0.23   Med: 4.09   Max: 9.39
Current: 0.23

During the past 9 years, Invent Medic Sweden AB's highest Cash Ratio was 9.39. The lowest was 0.23. And the median was 4.09.

XSAT:IMS's Cash Ratio is ranked worse than
81.46% of 852 companies
in the Medical Devices & Instruments industry
Industry Median: 1.075 vs XSAT:IMS: 0.23

Invent Medic Sweden AB Cash Ratio Historical Data

The historical data trend for Invent Medic Sweden AB's Cash Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Invent Medic Sweden AB Cash Ratio Chart

Invent Medic Sweden AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash Ratio
Get a 7-Day Free Trial Premium Member Only 4.15 4.95 0.92 0.59 0.23

Invent Medic Sweden AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cash Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.59 0.20 0.18 0.13 0.23

Competitive Comparison of Invent Medic Sweden AB's Cash Ratio

For the Medical Devices subindustry, Invent Medic Sweden AB's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Invent Medic Sweden AB's Cash Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Invent Medic Sweden AB's Cash Ratio distribution charts can be found below:

* The bar in red indicates where Invent Medic Sweden AB's Cash Ratio falls into.


;
;

Invent Medic Sweden AB Cash Ratio Calculation

The Cash Ratio measures a company's ability to meet its short-term obligations with its cash and near-cash resources.

Invent Medic Sweden AB's Cash Ratio for the fiscal year that ended in Dec. 2024 is calculated as:

Cash Ratio (A: Dec. 2024 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=1.248/5.426
=0.23

Invent Medic Sweden AB's Cash Ratio for the quarter that ended in Dec. 2024 is calculated as:

Cash Ratio (Q: Dec. 2024 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=1.248/5.426
=0.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Invent Medic Sweden AB  (XSAT:IMS) Cash Ratio Explanation

The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.

The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.

In general, the higher the cash ratio, the better the company's liquidity position.


Invent Medic Sweden AB Cash Ratio Related Terms

Thank you for viewing the detailed overview of Invent Medic Sweden AB's Cash Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Invent Medic Sweden AB Business Description

Traded in Other Exchanges
N/A
Address
Nytenkargatan 4, Lund, SWE, 223 63
Invent Medic Sweden AB develops and markets its product - Efemia bladder support, a vaginal medical device for the treatment of female urinary incontinence.

Invent Medic Sweden AB Headlines

From GuruFocus

Well-Known Companies Reach 52 Week Highs

By yifan900 yifan900 10-11-2016

5 Companies Reach 52-Week Highs

By yifan900 yifan900 02-13-2018

Healthcare Informatics: A Value Investor's Perspective

By Thomas Macpherson Thomas Macpherson 10-23-2015

Weekly Insider Sells Highlight: IMS, NOW, BMY, EA

By James Xiao James Xiao 08-11-2015

The Big 3: Larry Robbins' Top 2nd-Quarter Buys

By James Li James Li 08-16-2016